Miglitol 50 mg Australia

Description

Introduction

Miglitol 50 mg Australia is a tablet product containing 50 mg of miglitol. It is presented for type 2 diabetes. Miglitol belongs to a group of medicines called alpha-glucosidase inhibitors. It is used with diet and exercise to help improve blood glucose control, particularly the rise that follows a meal. A healthcare professional can assess whether miglitol belongs in an individual treatment plan.

What Is It?

Miglitol is an oral medicine that acts mainly in the small intestine. The 50 mg figure identifies the strength of each tablet, not an individual dose or dosing schedule. Miglitol may be used alone or with other diabetes medicines when a clinician considers combination treatment appropriate.

Type 2 diabetes requires ongoing management that may include food choices, physical activity, blood glucose monitoring and other medicines. The role of this tablet should be considered within that wider plan.

How Does It Work?

After a meal, enzymes in the small intestine break down some carbohydrates into sugars that can be absorbed into the bloodstream. Miglitol slows these enzymes. Carbohydrate digestion and sugar absorption therefore occur more slowly, reducing the rise in blood glucose after eating.

This action is related to food intake. Miglitol does not increase insulin release. Its effect and tolerability can vary, so blood glucose results and symptoms remain relevant when treatment is reviewed.

Common Uses

Miglitol is used alongside diet and exercise to improve blood glucose control in type 2 diabetes. Its effect is particularly relevant to blood glucose after meals. A clinician may consider it as a single medicine or alongside another glucose-lowering medicine.

It is not a treatment for diabetic ketoacidosis, a serious condition that requires urgent medical assessment. The need for miglitol and the choice of other diabetes medicines depend on a person’s clinical circumstances.

Available Strengths

This family is available in 25 mg, 50 mg.

Key Features

• Each tablet contains 50 mg of the active ingredient miglitol.
• The dosage form is an oral tablet.
• Miglitol is an alpha-glucosidase inhibitor.
• It slows the breakdown of carbohydrates in the small intestine.
• Its main glucose-lowering effect occurs after meals.

Benefits

• Miglitol can reduce the increase in blood glucose following a meal.
• Studies of miglitol have shown improvements in measures of blood glucose control when it is used with diet and exercise.
• Its mechanism differs from medicines that stimulate insulin release, giving clinicians another way to address blood glucose control.

These are effects of miglitol, not a promise of an individual result. Blood glucose measurements can help a healthcare professional assess response. A reduction in heart attack, stroke or other long-term complications has not been conclusively established for miglitol.

Possible Side Effects

• Flatulence or gas is a commonly reported digestive effect.
• Loose stools, diarrhoea and abdominal discomfort or pain can occur.
• Digestive effects often appear early in treatment and may lessen over time.
• Skin rash has been reported and should be discussed with a healthcare professional if it appears or persists.
• Low blood glucose may occur when miglitol is combined with insulin or a sulfonylurea medicine.

Persistent or severe digestive symptoms need medical review. Shaking, sweating, dizziness or unusual hunger may be signs of low blood glucose. Confusion, seizures or loss of consciousness require urgent medical attention.

Precautions

• Tell a healthcare professional about inflammatory bowel disease, colonic ulceration, bowel obstruction or another chronic intestinal condition before using miglitol.
• Discuss kidney disease before treatment, as reduced kidney function may affect exposure to miglitol.
• Raise any known allergy to miglitol or tablet ingredients before use. Ask a pharmacist to check the product’s ingredient information if needed.
• Discuss pregnancy, plans for pregnancy and breastfeeding with a healthcare professional.
• Diabetic ketoacidosis requires urgent care; miglitol is not used to treat it.

Additional Precautions

• Keep to the blood glucose monitoring plan advised by a healthcare professional, especially when miglitol is used with other diabetes medicines.
• Insulin and sulfonylureas can cause low blood glucose, and the risk may increase when either is used with miglitol.
• Glucose, also called dextrose, is preferred to table sugar for treating low blood glucose during miglitol treatment. Miglitol delays the breakdown of table sugar. Ask a healthcare professional for a personal low-glucose management plan.
• Missed or delayed meals, changes in exercise and alcohol use can affect blood glucose. Discuss substantial changes with the treating clinician.

Storage Instructions

• Keep the tablets out of the sight and reach of children.
• Keep the original packaging closed and protect the tablets from excess heat and moisture.
• Check the supplied pack for its exact storage directions and expiry date; ask a pharmacist if either is unclear.
• Ask a pharmacist how to dispose of tablets that are no longer needed.

How to Take

• Miglitol tablets are taken by mouth in connection with meals. Follow the directions given with the prescription.
• The 50 mg strength does not establish how many tablets to take or how often to take them.
• Ask a pharmacist or prescriber what to do if a meal is missed or a dose is forgotten. Do not double a dose to make up for one that was missed.
• Discuss troublesome digestive effects before changing or stopping a prescribed regimen.

Drug Interactions

• Insulin and sulfonylurea medicines may increase the risk of low blood glucose when used with miglitol.
• Intestinal adsorbents, such as charcoal, and digestive enzyme preparations containing carbohydrate-splitting enzymes may reduce miglitol’s effect.
• Miglitol can affect the absorption of some medicines, including propranolol and ranitidine. A healthcare professional can assess whether this matters for a particular combination.
• Tell a pharmacist or prescriber about prescription medicines, non-prescription products and supplements before starting treatment.

Why Choose This Product?

• It provides miglitol as a 50 mg oral tablet when a treatment plan calls for that ingredient and strength.
• Miglitol has a demonstrated effect on the rise in blood glucose after meals.
• Its action in the small intestine provides a distinct mechanism for blood glucose management.

Selection depends on medical history, other medicines, blood glucose results and tolerability. Ask a healthcare professional for product-specific guidance.

Frequently Asked Questions (FAQs)

What is the active ingredient?

Each tablet contains 50 mg of miglitol.

What type of medicine is miglitol?

It is an alpha-glucosidase inhibitor that slows carbohydrate breakdown in the small intestine.

What is miglitol used for?

It is used with diet and exercise to improve blood glucose control in type 2 diabetes.

Does it affect blood glucose after meals?

Yes. Its main effect is to reduce the rise in blood glucose after eating.

Can miglitol cause low blood glucose?

The risk increases when it is used with insulin or a sulfonylurea. Discuss monitoring with a healthcare professional.

What side effects are common?

Gas, loose stools, diarrhoea and abdominal discomfort are commonly reported.

Is it appropriate for someone with bowel disease?

Some bowel conditions are reasons not to use miglitol. A healthcare professional should assess the specific condition.

Can it be used during pregnancy or breastfeeding?

Ask a healthcare professional for guidance before using it during pregnancy or breastfeeding.

What should happen after a missed dose?

Ask a pharmacist or prescriber for advice that fits the prescribed regimen. Do not double a dose.

Does miglitol treat diabetic ketoacidosis?

No. Diabetic ketoacidosis requires urgent medical assessment and treatment.

Related Products

• Miglitol 25 mg Australia
• Miglitol 50 mg Australia
• Glimepiride 1 mg Australia
• Bromocriptine 2.5 mg Australia
• Repaglinide 2 mg Australia
• Acarbose 25 mg Australia